LCTX
Lineage Cell Therapeutics Inc
0.9303$
+2.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +200.0% | +245.8% | -94.9% | +189.4% | +154.8% | +43.8% | +23.7% | +31.2% | +28.7% | -10.0% | +43.7% | +28.0% | +91.2% | +18.3% | -61.1% | +69.0% | -32.0% | +30.2% | -11.1% | -20.4% | -21.0% | +4.4% | -47.7% | +404.0% | +277.4% | -39.2% | +6.2% | +53.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +82.5% | +5.6% | +32.2% | -67.7% | -53.1% | +79.8% | +36.4% | -6.6% | +270.4% | -48.9% | -7.8% | -50.2% | +153.0% | |
| – | +0.0% | +200.0% | +265.7% | -88.3% | +18.7% | +154.8% | +43.8% | +23.7% | +31.2% | +28.7% | -10.0% | +43.7% | +28.0% | +91.2% | +18.3% | -71.1% | +64.3% | -46.4% | +28.6% | +32.7% | -14.3% | -31.4% | -4.3% | -63.6% | +536.6% | +465.8% | -40.8% | +10.8% | +49.6% | |
| – | +0.0% | -19.0% | +188.3% | -31.4% | -49.9% | -34.5% | -18.2% | +24.4% | +35.8% | -6.8% | -31.9% | +76.3% | +74.0% | +165.8% | +73.6% | +32.2% | +46.9% | +41.1% | +13.5% | -15.3% | -33.5% | -12.8% | -14.3% | -31.4% | +175.3% | -58.8% | +12.3% | -20.6% | +42.2% | |
| – | +0.0% | +0.0% | +58.1% | -6.2% | +10.2% | -32.8% | -4.4% | +17.7% | -6.0% | +6.9% | -12.8% | +101.5% | -5.5% | +127.8% | +65.6% | +11.0% | +50.1% | +12.8% | +65.9% | -2.4% | -29.9% | +24.1% | -2.8% | -35.2% | +17.0% | +23.6% | -23.1% | +5.0% | +1.6% | |
| – | +57.1% | -27.3% | +185.7% | -23.9% | -30.1% | -33.6% | -7.2% | +18.3% | +10.0% | -0.3% | -22.1% | +90.7% | +25.9% | +148.5% | +70.3% | +14.0% | +54.6% | +27.6% | +29.8% | -9.5% | -30.5% | -0.4% | -5.1% | -32.8% | +92.6% | -29.4% | -9.6% | -7.2% | +15.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | -40.9% | -30.8% | -81.9% | +5,181.7% | -97.0% | +144.2% | +98.9% | -89.2% | +5,605.9% | +71.2% | -92.5% | +71.2% | +43.4% | +8,449.2% | -99.7% | +273.4% | +119.7% | -7.4% | +1,471.1% | -84.5% | +206.4% | -100.0% | +258,950.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -225.1% | – | – | – | – | – | – | – | – | |
| – | -300.0% | – | -659.7% | – | – | +1,482.9% | -363.0% | – | -104.3% | – | – | -103.9% | – | – | -169.7% | – | – | – | – | – | – | – | – | – | – | – | -433.3% | – | -19,040.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -159.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.